Pain-sensing neurons in the gut kindle inflammatory immune responses that cause allergies and asthma, according to a new ...
China: Researchers have found in a new meta-analysis that mepolizumab is an effective and safe treatment for severe ...
Among patients with asthma-like symptoms in primary care, testing using home spirometry may be useful for the diagnosis of ...
GSK’s Exdensur receives Japan’s MHLW approval for severe asthma and chronic rhinosinusitis with nasal polyps: London, UK Wednesday, January 7, 2026, 10:00 Hrs [IST] GSK plc an ...
GSK has secured approval in Japan for Exdensur (depemokimab), the country’s first ultra-long-acting biologic for severe asthma and chronic rhinosinusitis with nasal polyps. Approved by Japan’s ...
Collaborating institutions in Taiwan report higher risks of atopic disease among children conceived via assisted reproductive ...
TipRanks on MSN
Apogee Therapeutics reports positive Phase 1b asthma results
Apogee Therapeutics ( ($APGE) ) has provided an announcement. On January 6, 2026, Apogee Therapeutics reported positive interim results from a ...
The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...
China NMPA approves GSK’s Nucala to treat adults with chronic obstructive pulmonary disease: London, UK Tuesday, January 6, 2026, 10:00 Hrs [IST] GSK plc announced that China’ ...
Dr Lata BichileMK, a 42-year-old engineer, walked into my OPD along with his wife in August 2023. He had been experiencing ...
Statins were linked to decreased risk for acute asthma exacerbations in mild asthma and had a significant protective effect in Black patients.
GSK has high hopes for Nucala thanks to its less frequent dosing – once a month, versus every other week for Dupixent – and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback